The Latest

• May 11, 2022

  By Charleston Lim

  Pfizer To Acquire Migraine Drug Maker Biohaven For $11.6 Billion

  Pfizer's offer represents a 78.6% premium to Biohaven Pharmaceutical's latest closing price.

  

  Pfizer's offer represents a 78.6% premium to Biohaven Pharmaceutical's latest closing price.